The role of the calcium-dependent enzymes nitric oxide synthase and calpain in hypoxia-induced proximal tubule injury

Renal Failure

Volumn 18, Issue 3, 1996, Pages 501-511

  Edelstein, Charles L ^a   Yaqoob, Mohammad M ^a   Schrier, Robert W ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; APOPTOSIS; CELL DAMAGE; CELL DEATH; CELL SURVIVAL; CONFERENCE PAPER; ENZYME ACTIVATION; ENZYME ACTIVITY; HYPOXIA; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; REOXYGENATION;

EID: 0030011376     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229609052821     Document Type: Conference Paper

References (73)

1. Kjellstrand CM, Solez K: Treatment of acute renal failure. In: Schrier RW, Gottschalk CW (eds), Diseases of the Kidney. Boston, Little, Brown, 1992, p 1371.
2. Schrier RW, Burke TJ, Conger JD, Arnold PE: New aspects of acute renal failure. Proc 8th Int Cong Nephrol, Athens. Karger, 1981, p 63.
3. 2+ paradox). Cardiovasc Res 1:201-209, 1967.
4. 2+ dependence of toxic cell death: a final common pathway. Science 206:700-702, 1979.
5. 2+ in cell death. Life Sci 29:1289-1295, 1981.
6. + pump inhibition and metabolic inhibition in cultured neonatal rat cardiac myocytes. J Clin Invest 83:1876-1877, 1989.
7. 2+ and mitochondrial membrane potential preceding cell death in hepatocytes. Nature 78:352-354, 1987.
8. Burke TJ, Arnold PE, Gordon JA, Bulger RE, Dobyan DC, Schrier RW: Protective effects of intrarenal calcium membrane blockers before or after renal ischemia. functional, morphological and mitochondrial studies. J Clin Invest 74:1830-1841, 1984.
9. 2+ in cell injury. In Goligorsky MS (ed), Acute Renal Failure: Emerging New Concepts and Therapeutic Strategies, New York, Churchill Livingstone, 1995, p 3.
10. 2+ channel blockers in anoxia- and hypoxia-induced proximal tubule injury. J Pharmacol Exp Ther 260:526-532, 1992.
11. 2+ as determinants of anoxic cell death in primary renal cell cultures. Kidney Int 29:1172-1179, 1986.
12. 2+ channel blockers and calmodulin binding drugs on in vitro renal cell hypoxia. J Pharmacol Exp Ther 238:119-124, 1986.
13. 2+ modulation and cell injury in isolated rat proximal tubules. J Pharmacol Exp Ther 267:176-180, 1993.
14. 2+-induced mitochondrial swelling and respiratory dysfunction. J Pharmacol Exp Ther 273:206-212, 1995.
15. 2-induced injury in rat proximal tubules. Am J Physiol 264:F94-F99, 1993.
16. 2+ uptake, fatty acid, and LDH release during proximal tubule hypoxia: effects of mepacrine and dibucaine. Am J Physiol 266:F196-F201, 1994.
17. Kribben A, Wetzels JFM, Wieder ED, Burke TJ, Schrier RW: New technique to assess hypoxia-induced cell injury in individual isolated renal tubules. Kidney Int 43:464-469, 1993.
18. 2+ in hypoxia induced proximal tubular injury. J Clin Invest 93:1922-1929, 1994.
19. Hawkins HK, Ericsson JLE, Biberfeld P, Trump BF: Lysosomal and phagosome stability in lethal cell injury. Am J Pathol 68:255-288, 1972.
20. Suzuki K, Saido TC, Hirai S: Modulation of cellular signals by calpain. Ann NY Acad Sci 674:218-227, 1992.
21. 2+ dependent proteases: an enzyme system active at cellular membranes. FASEB J 1:110-115, 1987.
22. Saido TC, Sorimachi H, Suzuki K: Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J 8:814-822, 1994.
23. 2+-proteases (calpain I and II) as demonstrated using discriminative antibodies. J Biol Chem 259:9847, 1984.
24. Wang KW, Villalobo A, Roufogalis BD: Calmodulin binding proteins as calpain substrates. Biochem J 262: 693-706, 1989.
25. Scherberich JE, Wolf G, Stuckhardt C, Kugler P, Schoeppe W: Characterization and clinical role of glomerular and tubular proteases from human kidney. Adv Exp Med Biol 240:275-282, 1988.
26. Wilson PD, Hartz PA: Mechanisms of cyclosporin A toxicity in defined cultures of renal tubule epithelia: a role of cysteine proteases. Cell Biol Int Rep 15:1243-1255, 1991.
27. 2+ activated neutral proteases in epithelial tissues. Biochem Biophys Res Commun 148:567-574, 1987.
28. Wilson PD, Firestone RE, Lenard J: The role of lysosomal enzymes in killing of mammalian cells by the lysosomotropic detergent n-dodecylimidazole. J Cell Biol 104:1223-1229, 1987.
29. Lee KS, Frans S, Vanderklish P, Arai A, Lynch G: Inhibition of proteolysis protects hippocampal neurons from ischemia. Proc Natl Acad Sci USA 88:7233-7237, 1991.
30. Bronk SF, Gores GJ. pH dependent non Iysosomal proteolysis contributes to lethal anoxic injury of rat hepatocytes. Am J Physiol 264 (Gastrointest Liver Physiol 27):G744-G751, 1993.
31. Lizuka K, Kawaguchi H, Yasuda H: Calpain is activated during hypoxic myocardial cell injury. Biochem Med Metab Biol 46:427-431, 1991.
32. 2+ dependent proteolysis and its inhibition in ischemic rat myocardium. Can J Cardiol 2:442-447, 1986.
33. Edelstein CL, Wieder ED, Yaqoob M, Gengaro P, Burke TJ, Nemenoff R, Schrier RW: The role of cysteine proteases in hypoxia-induced proximal tubular injury. Proc Natl Acad Sci USA 92:7662-7666, 1995.
34. Wang KK, Yuen PW, Posner A, Raser KJ, Buroker-Kiljore M, Probert AW, Marcoux FW, Hays SJ, Lunney E, Hajimohammadreza I: Alpha-mercaptoacrylate derivatives as novel selective calpain inhibitors. In: Proc 10th Int Conf Intracell Protein Metab, Tokyo, Japan, 1994.
35. Mehdi S: Cell penetrating inhibitors of calpain. Trends Biochem Sci 16:150-153, 1991.
36. Wang KKW, Yuen PW: Calpain inhibition: an overview of its therapeutic potential. TiPS 15:412-419, 1994.
37. Edelstein CL, Wieder ED, Gengaro P, Burke TJ, Schrier RW: Hypoxia induced calpain activation in rat proximal tubules. J Am Soc Nephrol 5:896, 1994 (abstract).
38. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051-3064, 1992.
39. Moncada S, Palmer R, Higgs E: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142, 1991.
40. Bredt D, Hwang P, Snyder S: Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347:768-770, 1990.
41. Nathan C, Xie QW: Regulation of biosynthesis of nitric oxide. J Biol Chem 269:13725-13728, 1994.
42. Cho HJ, Xie QW, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Nathan C: Calmodulin is a subunit of nitric oxide synthase from macrophages. J Exp Med 176:599-604, 1992.
43. Baylis C, Mitruka B, Deng A: Chronic blockade of nitric oxide synthesis in rat produces systemic hypertension and glomerular damage. J Clin Invest 90:278-281, 1992.
44. Nava E, Palmer RMJ, Moncada S. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet 338:1555-1557, 1991.
45. Craven PA, Studer RK, DeRubertis FR: Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. J Clin Invest 93:311-320, 1994.
46. Schmidt HHW, Walter U. NO at work. Cell 78:919-925, 1994.
47. Choi DW: Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634, 1988.
48. Meldrum B, Garthwaite J: Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 11:379-387, 1990.
49. Choi DW: Bench to bedside: the glutamate connection. Science 9:241-243, 1992.
50. Mayer ML, Benveniste M, Patneau DK, Vyklicky L Jr: Pharmacologic properties of MMDA receptors. Ann NY Acad Sci 648:194-204, 1992.
51. Dawson VL, Dawson TM, London ED, Bredt DS, Snyder SH: Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA 88:6368-6371, 1991.
52. Moncada C, Lekieffre D, Arvin B, Meldrum B: Effect of NO synthase inhibition on NMDA- and ischaemia-induced hippocampal lesions. Neuroreport 3:530-532, 1992.
53. Nowicki JP, Duval D, Poignet H, Scatton B: Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur J Pharmacol 12:339-340, 1991.
54. Dawson TM, Steiner JP, Dawson VL, Dinerman JL, Uhl GR, Snyder SH: Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc Natl Acad Sci USA 90:9808-9812, 1993.
55. Romero JC, Lahera V, Salom MG, Biondi ML: Role of endothelium dependent relaxing factor, nitric oxide on renal function. J Am Soc Nephrol 2:1371-1387, 1992.
56. Mundel P, Bachmann S, Bader M, Fischer A, Kummer W, Mayer B, Kriz W: Expression of nitric oxide synthase in kidney macula densa cells. Kidney Int 42:1017, 1992.
57. Terada Y, Tomita K, Nonoguchi H, Marumo F: Polymerase chain reaction localisation of constitutive nitric oxide synthase and soluble guanylate cyclase messenger RNAs in microdissected rat nephron segments. J Clin Invest 90:659-665, 1992.
58. Yu L, Gengaro PE, Niederberger M, Burke TJ, Schrier RW: Nitric oxide: mediator in rat tubular hypoxia/ reoxygenation injury. Proc Natl Acad Sci USA 91:1691-1695, 1994.
59. Yaqoob M, Edelstein CL, Wieder ED, Gengaro P, Alkhunaizi A, Nemenoff R, Schrier RW: Neuronal nitric oxide synthase (nNOS): a mediator of hypoxic injury in rat proximal tubules. J Invest Med 43:351A, 1995 (abstract).
60. Shibuki K: An electrochemical microprobe for detecting nitric oxide release in brain tissue. Neurosci Res 9:69-76, 1990.
61. Fesus L, Davies PJA, Piacentini M: Apoptosis: molecular mechanisms in programmed cell death. Eur J Cell Biol 56:170-177, 1991.
62. Schumer M, Colombel MC, Sawczuk IS, Gobe G, Connor J, O'Toole KM, Olsson CA, Wise GJ, Buttyan R: Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol 140:831-838, 1992.
63. Olsen TS, Olsen HS, Hansen HE: Tubular ultrastructure in acute renal failure in man: epithelial necrosis and regeneration. Virchows Arch (A) 406:75-89, 1985.
64. Olsen S, Burdick JS, Keown PA, Wallace AC, Racusen LC, Solez K: Primary acute renal failure ("acute tubular necrosis") in the transplanted kidney: morphology and pathogenesis. Medicine 68:173-187, 1989.
65. Shimuza A, Yamanaka N: Apoptosis and cell desquamation in repair process of ischemic tubular necrosos. Virchows Archiv (B) Cell Pathol 64:171, 1993.
66. Squier MKT, Miller ACK, Cohen JJ: Calpain activation in apoptosis. J Cell Physiol 159:229-237, 1994.
67. Sarih M, Souvannavong V, Adam A: Nitric oxide synthase induces macrophage death by apoptosis. Biochem Biophys Res Commun 191:503-508, 1993.
68. Yaqoob M, Edelstein CL, Wieder ED, Gengaro P, Alkhunaizi A, Nemenoff R, Schrier RW: In-situ end labelling (ISEL) method to detect apoptosis in the presence of necrosis in hypoxic rat proximal tubular injury. J Invest Med 43:290A, 1995 (abstract).
69. Zhang J, Dawson VL, Dawson TW, Snyder SH: Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263:687-689, 1994.
70. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA; Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and Superoxide. Proc Natl Acad Sci USA 87:1620-1624, 1990.
71. Clancy RM, Leszczynska-Piziak J, Abramson SB: Nitric oxide stimulates the ADP-ribosylation of actin in human neutrophils. Biochem Biophys Res Commun 191:847-852, 1993.
72. 2+-dependent protease. Biochemistry 27:2205-2211, 1988.
73. Kobryn C, Mandel LJ: Decreased protein phosphorylation induced by anoxia in proximal renal tubules. Am J Physiol 267:C1073-C1079, 1994.